🚀 VC round data is live in beta, check it out!
Prim Valuation Multiples
Discover revenue and EBITDA valuation multiples for Prim and similar public comparables like Standard Glass Lining, Tristel, Stille, Bastide Le Confort Médical and more.
Prim Overview
About Prim
Prim SA is engaged in the provision of hospital supplies. The company is in a hospital and orthopedic supplies and materials for physiotherapy, thalassotherapy, thermal therapy, rehabilitation, geriatrics, as well as daily living aids. Prim work across a division of healthcare units such as Operating Theatres; Pain Management Centres; Plastic Surgery; Endosurgery and Cardiovascular.
Founded
1966
HQ
Employees
563
Website
Sectors
Financials (FY)
EV
$250M
Prim Financials
Prim reported last fiscal year revenue of $294M and EBITDA of $40M.
In the same fiscal year, Prim generated $148M in gross profit, $40M in EBITDA, and $19M in net income.
Prim P&L
In the most recent fiscal year, Prim reported revenue of $294M and EBITDA of $40M.
Prim expects next 12-month revenue of XXX and NTM EBITDA of XXX
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue | — | XXX | $294M | XXX | XXX | XXX |
| Gross Profit | — | XXX | $148M | XXX | XXX | XXX |
| Gross Margin | — | XXX | 50% | XXX | XXX | XXX |
| EBITDA | — | XXX | $40M | XXX | XXX | XXX |
| EBITDA Margin | — | XXX | 13% | XXX | XXX | XXX |
| EBIT Margin | — | XXX | 9% | XXX | XXX | XXX |
| Net Profit | — | XXX | $19M | XXX | XXX | XXX |
| Net Margin | — | XXX | 7% | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
Prim Stock Performance
Prim has current market cap of $259M, and enterprise value of $250M.
Market Cap Evolution
Prim's stock price is $15.22.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $250M | $259M | -1.4% | XXX | XXX | XXX | $1.14 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialPrim Valuation Multiples
Prim trades at 0.9x EV/Revenue multiple, and 6.3x EV/EBITDA.
Prim Financial Valuation Multiples
As of April 11, 2026, Prim has market cap of $259M and EV of $250M.
Equity research analysts estimate Prim's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Prim has a P/E ratio of 13.3x.
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $259M | XXX | $259M | XXX | XXX | XXX |
| EV (current) | $250M | XXX | $250M | XXX | XXX | XXX |
| EV/Revenue | — | XXX | 0.9x | XXX | XXX | XXX |
| EV/EBITDA | — | XXX | 6.3x | XXX | XXX | XXX |
| EV/EBIT | — | XXX | 9.5x | XXX | XXX | XXX |
| EV/Gross Profit | — | XXX | 1.7x | XXX | XXX | XXX |
| P/E | — | XXX | 13.3x | XXX | XXX | XXX |
| EV/FCF | — | XXX | 11.8x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Prim Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.
Prim Margins & Growth Rates
Prim's revenue in the last fiscal year grew by 8%.
Prim's revenue per employee in the last FY averaged $0.5M, while opex per employee averaged $0.2M for the same period.
Prim Operational Valuation Multiples
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue Growth | — | XXX | 8% | XXX | XXX | XXX |
| EBITDA Margin | — | XXX | 13% | XXX | XXX | XXX |
| EBITDA Growth | — | XXX | 29% | XXX | XXX | XXX |
| Revenue per Employee | — | XXX | $0.5M | XXX | XXX | XXX |
| Opex per Employee | — | XXX | $0.2M | XXX | XXX | XXX |
| Opex to Revenue | — | XXX | 42% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Prim Public Comps
See public comps and valuation multiples for other Medical Supplies comps.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| LTM | 2026E | 2027E | LTM | 2026E | 2027E | |
| Standard Glass Lining | XXX | XXX | XXX | XXX | XXX | XXX |
| Tristel | XXX | XXX | XXX | XXX | XXX | XXX |
| Stille | XXX | XXX | XXX | XXX | XXX | XXX |
| Bastide Le Confort Médical | XXX | XXX | XXX | XXX | XXX | XXX |
| Paragon Care | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Prim M&A Activity
Prim acquired XXX companies to date.
Last acquisition by Prim was on XXXXXXXX, XXXXX. Prim acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Acquisitions by Prim
| Acquired Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Get Verified M&A Valuation Multiples
Sign up to see revenue and EBITDA valuation multiples for 150K+ M&A deals.
Start Free TrialPrim Investment Activity
Prim invested in XXX companies to date.
Prim made its latest investment on XXXXXXXX, XXXXX. Prim invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Investments by Prim
| Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Prim
| When was Prim founded? | Prim was founded in 1966. |
| Where is Prim headquartered? | Prim is headquartered in Spain. |
| How many employees does Prim have? | As of today, Prim has over 563 employees. |
| Is Prim publicly listed? | Yes, Prim is a public company listed on Bolsa de Madrid. |
| What is the stock symbol of Prim? | Prim trades under PRM ticker. |
| When did Prim go public? | Prim went public in 1997. |
| Who are competitors of Prim? | Prim main competitors are Standard Glass Lining, Tristel, Stille, Bastide Le Confort Médical. |
| What is the current market cap of Prim? | Prim's current market cap is $259M. |
| What is the current revenue of Prim? | Prim's last fiscal year revenue is $294M. |
| What is the current EV/Revenue multiple of Prim? | Current revenue multiple of Prim is 0.9x. |
| Is Prim profitable? | No, Prim is not profitable. |
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.